Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mione

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
The International Journal of Biological Markers|July 1, 1991
TAF test in primary esophageal carcinoma: comparison with other tumor markersW Taccone, M Gion, F Pecchio, et al.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1993
A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancerM Gion, G Ruggeri, R Mione, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
European Urology|January 1, 1992
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?S Omacini, R Mione, M Barichello, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
The International Journal of Biological Markers|July 1, 1991
TAF test in primary esophageal carcinoma: comparison with other tumor markersW Taccone, M Gion, F Pecchio, et al.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1993
A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancerM Gion, G Ruggeri, R Mione, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
European Urology|January 1, 1992
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?S Omacini, R Mione, M Barichello, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
Pageof 5